These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18619946)

  • 1. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.
    Zhu H; Wu H; Liu X; Evans BR; Medina DJ; Liu CG; Yang JM
    Biochem Pharmacol; 2008 Sep; 76(5):582-8. PubMed ID: 18619946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells].
    Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
    Zou Z; Zou R; Zong D; Shi Y; Chen J; Huang J; Zhu J; Chen L; Bao X; Liu Y; Liu W; Huang W; Hu J; Chen Z; Lao X; Chen C; Huang X; Lu Y; Ni X; Fang D; Wu D; Lu S; Jiang M; Qiu C; Wu Y; Qiu Q; Dong Y; Su Y; Zhao C; Zhong Z; Cai J; Liang Y
    J Cell Mol Med; 2017 Sep; 21(9):1929-1943. PubMed ID: 28411377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.
    Feng DD; Zhang H; Zhang P; Zheng YS; Zhang XJ; Han BW; Luo XQ; Xu L; Zhou H; Qu LH; Chen YQ
    J Cell Mol Med; 2011 Oct; 15(10):2164-75. PubMed ID: 21070600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
    Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
    Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
    Zhang H; Li M; Han Y; Hong L; Gong T; Sun L; Zheng X
    Dig Dis Sci; 2010 Sep; 55(9):2545-51. PubMed ID: 19960259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 130b enhances drug resistance in human ovarian cancer cells.
    Zong C; Wang J; Shi TM
    Tumour Biol; 2014 Dec; 35(12):12151-6. PubMed ID: 25155039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
    Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P
    PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of deoxyribozyme with high reversal efficiency against multidrug resistance in breast carcinoma cells.
    Gao P; Wei JM; Li PY; Zhang CJ; Jian WC; Zhang YH; Xing AY; Zhou GY
    J Cell Mol Med; 2011 Oct; 15(10):2130-8. PubMed ID: 21155975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a.
    Zhao Q; Li Y; Tan BB; Fan LQ; Yang PG; Tian Y
    PLoS One; 2015; 10(8):e0132746. PubMed ID: 26292288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier.
    Hammad S; Mabondzo A; Hamoudi R; Harati R
    J Pharm Sci; 2022 May; 111(5):1470-1479. PubMed ID: 34695419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
    Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
    Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
    Boyerinas B; Park SM; Murmann AE; Gwin K; Montag AG; Zillhardt M; Hua YJ; Lengyel E; Peter ME
    Int J Cancer; 2012 Apr; 130(8):1787-97. PubMed ID: 21618519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells.
    Takwi AA; Wang YM; Wu J; Michaelis M; Cinatl J; Chen T
    Oncogene; 2014 Jul; 33(28):3717-29. PubMed ID: 23934188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.